Ipamorelin/CJC-1295 (No DAC)

This blend combines two peptides from different growth-hormone-related pathways in one vial: CJC-1295 in its shorter, non-DAC form (meaning it lacks the Drug Affinity Complex modification that some other CJC-1295 products carry, which otherwise extends how long a peptide persists in solution), and Ipamorelin, a five-amino-acid peptide that targets the ghrelin receptor rather than the GHRH receptor. Pairing a GHRH-pathway peptide with a ghrelin-pathway peptide is a common combination in this product category because the two act on separate but related signaling routes. The blend is supplied as a single lyophilized powder for researchers who want both reference compounds together rather than sourcing and combining them separately.

Research Applications Noted

• Analytical evaluation of peptide structure and sequence characteristics
• Examination of stability and degradation profiles of combined systems
• Investigation of peptide behavior in biochemical and cell-based assays
• Characterization of interactions between blend components